333-055-0030 Certificates of Completion of Training (1) Persons who successfully complete educational training under OAR 333-055-0000 through 333-055-0035 shall be given a Public Health Division statement of completion signed by the individual conducting the training. The statement of completion for the treatment of allergic response training may also be used as an authorization to obtain epinephrine if fully completed and personally signed by a nurse practitioner or a physician responsible for the training program. (a) A statement of completion for the treatment of allergic response training may be obtained from the Oregon Health Authority, Public Health Division, 800 NE Oregon Street, Suite 290, Portland, Oregon 97232, Phone: (971) 673-1230. (b) A statement of completion for emergency glucagon providers is included in the training protocol available at http://healthoregon.org/diabetes. (c) A statement of completion for school personnel trained in the administration of a medication to treat adrenal crisis is included in the treatment of adrenal insufficiency protocol available at http://healthoregon.org/ems. (2) The statement of completion and authorization to obtain epinephrine form allows a pharmacist to generate a prescription and dispense an emergency supply of epinephrine for not more than one child and one adult in an automatic injection device if signed by a nurse practitioner or physician. Whenever such a statement of completion form for an emergency supply of epinephrine is presented, the pharmacist shall write upon the back of the statement of completion form in non-erasable ink the date that the prescription was filled, returning the statement of completion to the holder. The prescription may be filled up to four times. The pharmacist who dispenses an emergency supply of epinephrine under this rule shall also reduce the prescription to writing for his files, as in the case of an oral prescription for a non-controlled substance, and file the same in the pharmacy. (3) A person who has successfully completed educational training in the administration of glucagon may receive, from the parent or guardian of a student, doses of glucagon prescribed by a health care professional with appropriate prescriptive privileges licensed under ORS chapters 677 or 678, and the necessary paraphernalia for administration. (4) A person who has successfully completed educational training in the administration of a medication to treat adrenal crisis may receive, from the parent or guardian of a student, medication that treats adrenal insufficiency prescribed by a health care professional with appropriate prescriptive privileges licensed under ORS Chapters 677 or 678, and the necessary paraphernalia for administration. (5) Completion of a training program and receipt of a statement of completion does not guarantee the competency of the individual trained. (6) A statement of completion and authorization to obtain epinephrine shall expire three years after the date of training identified on the statement of completion. Individuals trained to administer epinephrine, glucagon or a medication to treat adrenal insufficiency must be trained every three years in accordance with OAR 333-055-0015 in order to obtain a new statement of completion. (7) Individuals trained to administer epinephrine, glucagon or a medication to treat adrenal crisis may be asked to provide copies of a current statement of completion to their employers or to organizations or entities to which they volunteer. [ED. NOTE: Figures referenced are available from the agency.] Statutory/Other Authority: ORS 433.810 Statutes/Other Implemented: ORS 433.815, 433.817 & 433.825 History: PH 17-2017, minor correction filed 12/13/2017, effective 12/13/2017 PH 3-2016, f. & cert. ef. 2-8-16 PH 14-2012, f. & cert. ef. 9-19-12 PH 10-2004, f. & cert. ef. 3-23-04 OHD 7-1998, f. & cert. ef. 7-28-98 Reverted to HD 10-1982, f. & ef. 5-25-82 HD 23-1990(Temp), f. & cert. ef. 8-15-90 HD 10-1982, f. & ef. 5-25-82